Keene & Associates’s Henry Schein HSIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$352K Buy
5,086
+31
+0.6% +$2.23K 0.28% 66
2024
Q3
$369K Sell
5,055
-95
-2% -$6.59K 0.28% 61
2024
Q2
$330K Buy
5,150
+645
+14% +$45.4K 0.27% 60
2024
Q1
$340K Buy
4,505
+175
+4% +$13.1K 0.25% 67
2023
Q4
$328K Hold
4,330
0.27% 63
2023
Q3
$322K Sell
4,330
-125
-3% -$9.63K 0.26% 61
2023
Q2
$361K Buy
4,455
+125
+3% +$9.88K 0.28% 53
2023
Q1
$353K Sell
4,330
-450
-9% -$36.7K 0.27% 54
2022
Q4
$382K Hold
4,780
0.34% 44
2022
Q3
$314K Buy
4,780
+125
+3% +$9.28K 0.29% 53
2022
Q2
$357K Buy
4,655
+250
+6% +$21K 0.33% 48
2022
Q1
$384K Buy
4,405
+115
+3% +$9.37K 0.31% 50
2021
Q4
$333K Buy
+4,290
New +$328K 0.29% 58

Other funds holding HSIC

Keene & Associates's HSIC Position: Q4 2024 in Review

Keene & Associates increased its Henry Schein (HSIC) stake by 0.61% in Q4 2024, buying an estimated $2.23K and bringing the position to 5,086 shares worth $352K. The position accounts for 0.28% of the portfolio, ranked #66.

Keene & Associates first reported a position in HSIC in Q4 2021 and has held it in 13 quarters since. The position peaked at $384K in Q1 2022. 540 funds tracked by Wall St. Rank hold HSIC as of Q4 2024.

  • Keene & Associates held 5,086 shares of Henry Schein worth $352K as of Q4 2024.
  • Keene & Associates bought 31 Henry Schein shares in Q4 2024, an estimated $2.23K.
  • Henry Schein made up 0.28% of Keene & Associates's portfolio in Q4 2024, its #66 holding.
  • Keene & Associates first reported a position in Henry Schein in Q4 2021 and has held it in 13 quarters since.
  • Keene & Associates's Henry Schein position peaked at $384K in Q1 2022.
  • 540 funds tracked by Wall St. Rank held Henry Schein as of Q4 2024.

Based on Keene & Associates's 13F filing for Q4 2024, filed 3 Feb 2025.